ZOLIREST Trademark

Trademark Overview

On Wednesday, May 28, 2008, a trademark application was filed for ZOLIREST with the United States Patent and Trademark Office. The USPTO has given the ZOLIREST trademark a serial number of 79055727. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Monday, May 28, 2018. This trademark is owned by Orexo AB. The ZOLIREST trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of conditions and diseases connected to the central nervous system, namely, pain, insomnia and migraine
zolirest

General Information

Serial Number79055727
Word MarkZOLIREST
Filing DateWednesday, May 28, 2008
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateMonday, May 28, 2018
Registration Number3651343
Registration DateTuesday, July 7, 2009
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 21, 2009

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of conditions and diseases connected to the central nervous system, namely, pain, insomnia and migraine
Pseudo MarkZOLI REST

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, February 12, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameOrexo AB
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressSE
Party NameOrexo AB
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressSE
Party NameOrexo AB
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressSE

Trademark Events

Event DateEvent Description
Friday, December 28, 2018NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Friday, December 28, 2018DEATH OF INTERNATIONAL REGISTRATION
Friday, March 24, 2017TOTAL INVALIDATION PROCESSED BY THE IB
Tuesday, January 10, 2017GENERIC MADRID TRANSACTION SENT TO IB
Tuesday, January 10, 2017GENERIC MADRID TRANSACTION CREATED
Wednesday, October 12, 2016TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, February 12, 2016CANCELLED SECTION 71
Monday, January 28, 2013FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, October 16, 2009FINAL DISPOSITION NOTICE SENT TO IB
Friday, October 16, 2009FINAL DISPOSITION PROCESSED
Wednesday, October 7, 2009FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, July 7, 2009REGISTERED-PRINCIPAL REGISTER
Tuesday, April 21, 2009PUBLISHED FOR OPPOSITION
Wednesday, April 1, 2009NOTICE OF PUBLICATION
Friday, March 13, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, March 13, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 13, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 13, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 12, 2009ASSIGNED TO LIE
Thursday, March 12, 2009TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 11, 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, March 11, 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, October 3, 2008REFUSAL PROCESSED BY IB
Friday, September 12, 2008NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, September 12, 2008REFUSAL PROCESSED BY MPU
Friday, September 12, 2008NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, September 11, 2008NON-FINAL ACTION WRITTEN
Wednesday, September 10, 2008ASSIGNED TO EXAMINER
Thursday, August 14, 2008NEW APPLICATION ENTERED IN TRAM
Thursday, August 7, 2008SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

zolirest namely system pain insomnia migraine nervous central treatment preparations conditions